BCLI - ブレインスト―ム・セル・セラピュ―ティクス (Brainstorm Cell Therapeutics Inc.)

BCLIのニュース

   Stem Cell Characterization and Analysis Tool Market 2021 Research including Growth Factors, Global Survey, Development Strategy: BrainStorm Cell Therapeutics Inc.  2021/08/13 05:33:43 OpenPR
The research report Global Stem Cell Characterization and Analysis Tool Market provides thorough information on market share analysis, market size, consumer volume, key market sectors, diverse regions, key market participants and industry / business tactics. The competitive scenario section of
   BrainStorm Cell Therapeutics EPS beats by $0.05  2021/08/05 11:11:18 Seeking Alpha
   Is Brainstorm Cell Therapeutics Inc. (BCLI) A Good Stock To Buy?  2021/06/22 23:17:14 Insider Monkey
   Brainstorm Announces Expansion of NurOwn® IP Portfolio with Grant and Allowance of Multiple Patents and Applications in Major Markets  2021/06/15 13:21:00 Business Insider Markets
NEW YORK, June 15, 2021 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the grant and/or allowance of a series of patents and patent
   Brainstorm Cell Therapeutics: MSC-NTF Cell Therapy Shows Mid-Stage Promise In PMS  2021/05/30 17:05:25 Seeking Alpha
   Is Brainstorm Cell Therapeutics Inc. (BCLI) A Good Stock To Buy?  2021/06/22 23:17:14 Insider Monkey
   Brainstorm Announces Expansion of NurOwn® IP Portfolio with Grant and Allowance of Multiple Patents and Applications in Major Markets  2021/06/15 13:21:00 Business Insider Markets
NEW YORK, June 15, 2021 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the grant and/or allowance of a series of patents and patent
   Brainstorm Cell Therapeutics: MSC-NTF Cell Therapy Shows Mid-Stage Promise In PMS  2021/05/30 17:05:25 Seeking Alpha
   Global Gene and Cell Therapies Targeting CNS Disorders Market 2021-2026 Featuring Emerging Drugs - NurOwn (BrainStorm Cell Therapeutics) & Neuro-Cells (Neuroplast)  2021/05/26 10:18:00 GlobeNewswire
Dublin, May 26, 2021 (GLOBE NEWSWIRE) -- The "Gene and Cell Therapies Targeting CNS Disorders - Market Insights and Market Forecast - 2026" report has been added to ResearchAndMarkets.com''s offering.
   BrainStorm Announces Scientific Presentation of NurOwn® Exosome Preclinical ARDS Data at ISCT 2021 New Orleans VIRTUAL Meeting  2021/05/25 20:21:00 Finanzen AT
NEW YORK, May 25, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced the presentation today of a poster titled, "Molecular Mechanisms Underlying MSC-NTF
   Brainstorm Cell Therapeutics: MSC-NTF Cell Therapy Shows Mid-Stage Promise In PMS  2021/05/30 17:05:25 Seeking Alpha

calendar